Edwards Lifesciences develops and sells medical devices for treating advanced cardiovascular conditions globally, with operations across the United States, Europe, Japan, and other markets. The company manufactures transcatheter valve replacement systems for less-invasive aortic interventions, along with repair and replacement options for mitral and tricuspid valve conditions, as well as surgical valve products for structural heart procedures. Its distribution network combines direct sales personnel with independent partners to deliver these cardiac care solutions to hospitals and medical facilities worldwide.
1Y: 88.25 (+18.4%) · range 72.65–95.18
entry readiness 38 · WEAK SETUP · exit proximity 0
Value area 81.64–91.93 · 29% of 120d volume overhead · moderate overhead
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.000 | Sep 17, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +2.17% | +5.45% | mature |
| 40d | -5.01% | +5.45% | 28/40d |